For decades, Chiesi Pharmaceuticals has been committed to neonatology, working alongside the medical community to improve the level of care for preterm infants.
 
Delivery normally occurs between the 37th and 42nd week of gestation. At that time, the fetus is fully formed and developed enough to be able to adapt to extra-uterine life. However, in some cases delivery may occur before the 37th week of gestation. In this case, the neonate is considered premature, with the degree of development of its organs depending on the gestational age.
 
The maturation and functionality of the lungs are critical to survival. Based on the degree of prematurity, the lungs may be partially or even completely immature and thus unable to ensure adequate respiratory function.

Thanks to this important relationship with the medical community, Chiesi has become a global partner for neonatologists, bringing its life-saving medicines to more than 80 countries around the world and working to share best clinical practices.
For more information on apnea of prematurity and neonatal respiratory distress syndrome (RDS),  click here.